GeneDx Shares Watch After Holder Filings in Holiday Week
GeneDx shares closed at $47.31 Friday, up 16% from last week but still 30% below early May levels after a post-earnings drop. SEC filings show Eli Casdin and Keith Meister now hold 13.7% and 17.9% stakes, respectively, after recent open-market purchases. The company cut 2026 revenue guidance and reported Q1 revenue of $102.3 million, missing expectations by $12 million. U.S. markets reopen Tuesday after Memorial Day.